Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  3. 10-K/A Report 10-K/A
  4. 8-K Event Results of operations
  5. 10-K Report Annual Report
  6. 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Code of ethics change
  7. 8-K Event Delisting notice
  8. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  9. 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  10. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  11. 8-K Event Other events
  12. 8-K Event Results of operations
  13. DEF 14A Proxy Proxy Statement
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Executive or director change · Other events
  16. 8-K Event Material agreement
  17. 8-K Event Material agreement · Delisting notice · Executive or director change
  18. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  19. 8-K Event Executive or director change · Other events
  20. 8-K Event Results of operations

Page 3 of 10 · 197 filings